The Italian Competition Authority closes its investigation into resale price maintenance in the market for probiotics following commitments from the alleged transgressor (SOFAR)

In May 2021, the Italian Competition Authority (AGCM or ICA) launched an investigation into restrictions on resale prices that a pharmaceutical company, SOFAR, was alleged to have imposed upon its distribution network for a probiotic product (Enterolactis Plus). In Europe, agreements or anomalous inducements between suppliers and distributors aimed at restricting the freedom of the latter to set their own resale prices (known as Resale Price Maintenance or “RPM”) constitute “hardcore” infringement of Article 101 of the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Enzo Marasà, Irene Picciano, Grazia Elenora Vita, The Italian Competition Authority closes its investigation into resale price maintenance in the market for probiotics following commitments from the alleged transgressor (SOFAR), 6 January 2022, e-Competitions February 2022, Art. N° 108706

Visites 39

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues